Author:
Tian Xingtao,Qin Bingjie,Lu Hong,Lai Weihong,Jiang Shibo,Lee Kuo-Hsiung,Chen Chin Ho,Xie Lan
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference16 articles.
1. From 4,5,6,7-Tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to Etravirine (TMC125): Fifteen Years of Research on Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase
2. Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse Transcriptase
3. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections
4. TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1
5. Gruzdev, B.; Horban, A.; Boron-Kaczmarska A.; Gille, D.; Van’t Klooster, G.; Pauwels, R. Abstr. 13, 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL, February 4–8, 2001.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献